{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:55:49Z","timestamp":1792706149251,"version":"4.5.0"},"reference-count":51,"publisher":"SAGE Publications","issue":"1-2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Eur J Mass Spectrom (Chichester)"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:p>In 2018, the Food and Drug Administration and the European Medicines Agency identified nitrosamine impurities in certain drugs, prompting detailed investigations by international regulatory authorities. According to ICH M7 (R1) guidelines, nitrosamines are classified as Class 1 substances, the most hazardous category, based on their carcinogenic and mutagenic properties. They are also recognized as probable human carcinogens by the International Agency for Research on Cancer. Since nitrosamine-induced DNA damage poses significant health risks, identifying potential nitrosamines in pharmaceutical products is crucial. In this study, a simple and efficient extraction method was designed to minimize matrix effects. These effects were evaluated using calibration curves prepared for each drug product in their respective matrices. The developed method was performed using an Agilent 1260 series HPLC system and an Agilent 6460 triple quadrupole tandem mass spectrometer. An Inertsil ODS-3 C18 (5 \u00b5m, 4.6\u2009\u00d7\u2009150 mm) column was employed for chromatographic separation. A triple quadrupole mass detector with electrospray ionization was used for detection, and multiple reaction monitoring was employed for quantification. The correlation coefficients (r\u00b2) were at least 0.999 for all eight nitrosamines. Limit of detection and limit of quantification values were determined as 0.05\u20130.8 ng\/mL and 0.1\u20132.0 ng\/mL, respectively. Validation results demonstrated satisfactory selectivity, accuracy, precision, and stability. The results demonstrated that the developed method is capable of reliably detecting potential nitrosamines present in pharmaceutical products at trace levels. This method contributes significantly to pharmaceutical safety and can serve as a valuable tool for future analyses.<\/jats:p>","DOI":"10.1177\/14690667251328823","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T17:05:08Z","timestamp":1742576708000},"page":"51-62","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["LC-ESI-MS\/MS method for the accurate quantification of eight nitrosamines in pharmaceutical products"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4646-4129","authenticated-orcid":false,"given":"Ibrahim","family":"Danis","sequence":"first","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Pharmacy; Drug Research Center; Institute of Health Science, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durisehvar Ozer","family":"Unal","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Pharmacy; Drug Research Center, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"167","article-title":"Some toxic properties of dimethylnitrosamine","volume":"11","author":"Barnes JM","year":"1954","unstructured":"Barnes JM, Magee PN. Some toxic properties of dimethylnitrosamine. Br J Ind Med 1954; 11: 167\u2013174.","journal-title":"Br J Ind Med"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1956.15"},{"key":"e_1_3_2_4_2","volume-title":"Chemistry and biology of N-nitroso compounds","author":"Lijinsky W","year":"1992","unstructured":"Lijinsky W. Chemistry and biology of N-nitroso compounds. Cambridge: Cambridge University Press, 1992."},{"key":"e_1_3_2_5_2","first-page":"643","volume-title":"Chemical Carcinogens","author":"Preussmann R","year":"1984","unstructured":"Preussmann R, Stewart BW. N-Nitroso carcinogens. In: Searle CE (ed.) Chemical Carcinogens. Washington, D.C: American Chemical Society, 1984, pp.643\u2013828."},{"key":"e_1_3_2_6_2","unstructured":"Nitrosamine impurities in human medicinal products. Committee for Medicinal Products for Human Use (CHMP) 2020."},{"key":"e_1_3_2_7_2","unstructured":"U.S. Food and Drug Administration. Control of Nitrosamine Impurities in Human Drugs: Guidance for Industry. Silver Spring: U.S. Food and Drug Administration. https:\/\/www.fda.gov\/media\/141720\/download"},{"key":"e_1_3_2_8_2","unstructured":"Nitrosamines and related N-nitroso compounds chemistry and biochemistry. In: (eds Loeppky RN Michejda CJ American Chemical Society. Division of A et al.) 1994 American Chemical Society."},{"key":"e_1_3_2_9_2","unstructured":"ICH M7. Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. M7 (R1) current step 2014 4."},{"key":"e_1_3_2_10_2","unstructured":"Cancer IAfRo. Agents classified by the IARC monographs volumes 1\u2013106. http:\/\/monographs iarc fr\/ENG\/Classification\/index php 2012."},{"key":"e_1_3_2_11_2","unstructured":"Shaikh T Gosar A Sayyed H. Nitrosamine Impurities in Drug Substances and Drug Products. 2020; 2: 48\u201357. DOI: https:\/\/doi.org\/10.5281\/zenodo.3629095."},{"key":"e_1_3_2_12_2","first-page":"1","article-title":"Presence of nitrosamine impurities in medicinal products","volume":"72","author":"Sedlo I","year":"2021","unstructured":"Sedlo I, Koloni\u0107 T, Tomi\u0107 S. Presence of nitrosamine impurities in medicinal products. Arh Hig Rada Toksikol 2021; 72: 1\u20135. 20210330.","journal-title":"Arh Hig Rada Toksikol"},{"key":"e_1_3_2_13_2","first-page":"33","article-title":"Assessing caffeine levels in soft beverages available in Istanbul, Turkey: an LC-MS\/MS application in food toxicology","volume":"35","author":"Y\u00fcksel B","year":"2023","unstructured":"Y\u00fcksel B, \u00d6nc\u00fc T, \u015een N. Assessing caffeine levels in soft beverages available in Istanbul, Turkey: an LC-MS\/MS application in food toxicology. Toxicol Anal Clin 2023; 35: 33\u201343.","journal-title":"Toxicol Anal Clin"},{"key":"e_1_3_2_14_2","volume-title":"Validation of analytical procedures Q2 (R1)","author":"Guideline I","year":"2022","unstructured":"Guideline I. Validation of analytical procedures Q2 (R1). Geneva, Switzerland: ICH; 2022."},{"key":"e_1_3_2_15_2","unstructured":"Volmer D Jessome LL. Ion suppression: a major concern in mass spectrometry. 2006."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0021-9673(04)01479-7","article-title":"The ECHO technique\u2013the more effective way of data evaluation in liquid chromatography\u2013tandem mass spectrometry analysis","volume":"1058","author":"Alder L","year":"2004","unstructured":"Alder L, L\u00fcderitz S, Lindtner K, et al. The ECHO technique\u2013the more effective way of data evaluation in liquid chromatography\u2013tandem mass spectrometry analysis. J Chromatogr A 2004; 1058: 67\u201379.","journal-title":"J Chromatogr A"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.38212\/2224-6614.1063","article-title":"A multi-analyte LC-MS\/MS method for screening and quantification of nitrosamines in sartans","volume":"28","author":"Chang SH","year":"2020","unstructured":"Chang SH, Chang CC, Wang LJ, et al. A multi-analyte LC-MS\/MS method for screening and quantification of nitrosamines in sartans. J Food Drug Anal 2020; 28: 292\u2013301. 20200615.","journal-title":"J Food Drug Anal"},{"key":"e_1_3_2_18_2","first-page":"541","article-title":"Development and validation of four nitrosamine impurities determination method in medicines of valsartan, losartan, and irbesartan with HPLC-MS\/MS (APCI)","volume":"20","author":"Khorolskiy M","year":"2021","unstructured":"Khorolskiy M, Ramenskaya G, Vlasov A, et al. Development and validation of four nitrosamine impurities determination method in medicines of valsartan, losartan, and irbesartan with HPLC-MS\/MS (APCI). Iran J Pharm Res 2021; 20: 541\u2013552.","journal-title":"Iran J Pharm Res"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.56530\/lcgc.eu.dd3576s1","article-title":"Low-level determination of mutagenic nitrosamine impurities in drug substances by LC\u2013MS\/MS","volume":"34","author":"James M","year":"2021","unstructured":"James M, Edge T. Low-level determination of mutagenic nitrosamine impurities in drug substances by LC\u2013MS\/MS. LCGC Europe 2021; 34: 267\u2013276.","journal-title":"LCGC Europe"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"114867","DOI":"10.1016\/j.jpba.2022.114867","article-title":"Simultaneous determination of 13 nitrosamine impurities in biological medicines using salting-out liquid-liquid extraction coupled with liquid chromatography tandem mass spectrometry","volume":"218","author":"Luo F","year":"2022","unstructured":"Luo F, Liu Y, Xie Y, et al. Simultaneous determination of 13 nitrosamine impurities in biological medicines using salting-out liquid-liquid extraction coupled with liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 2022; 218: 114867. 20220602.","journal-title":"J Pharm Biomed Anal"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10337-021-04115-x","article-title":"A critical N-nitrosamine impurity of anticoagulant drug, rivaroxaban: synthesis, characterization, development of LC\u2013MS\/MS method for nanogram level quantification","volume":"85","author":"Baksam V","year":"2022","unstructured":"Baksam V, Saritha N, Subba Rao DD, et al. A critical N-nitrosamine impurity of anticoagulant drug, rivaroxaban: synthesis, characterization, development of LC\u2013MS\/MS method for nanogram level quantification. Chromatographia 2022; 85: 1\u201310.","journal-title":"Chromatographia"},{"key":"e_1_3_2_22_2","article-title":"Method for trace determination of N-nitrosamines impurities in metronidazole benzoate using high-performance liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry","volume":"46","author":"Yin M","year":"2023","unstructured":"Yin M, Hu Y, Fan H, et al. Method for trace determination of N-nitrosamines impurities in metronidazole benzoate using high-performance liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry. J Sep Sci 2023; 46: e2200225. 20221230.","journal-title":"J Sep Sci"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"463605.","DOI":"10.1016\/j.chroma.2022.463605","article-title":"Development of dispersive inclusion complex microextraction for the analysis of nitrosamines in medicinal products","volume":"1685","author":"Tay KSJ","year":"2022","unstructured":"Tay KSJ, Breadmore MC, Soh ES, et al. Development of dispersive inclusion complex microextraction for the analysis of nitrosamines in medicinal products. J Chromatogr A 2022; 1685: 463605. 20221101.","journal-title":"J Chromatogr A"},{"key":"e_1_3_2_24_2","first-page":"20221103","article-title":"Determination of genotoxic impurity N-nitroso-N-methyl-4-aminobutyric acid in four sartan substances through using liquid chromatography-tandem mass spectrometry","volume":"27","author":"Xie B","year":"2022","unstructured":"Xie B, Guo D, Mai B, et al. Determination of genotoxic impurity N-nitroso-N-methyl-4-aminobutyric acid in four sartan substances through using liquid chromatography-tandem mass spectrometry. Molecules 2022; 27: 20221103.","journal-title":"Molecules"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/chromsci\/bmac059","article-title":"A multi-analyte LC-MS\/MS method for determination and quantification of six nitrosamine impurities in sartans like azilsartan, valsartan, telmisartan, olmesartan, losartan and irbesartan","volume":"62","author":"Gopireddy RR","year":"2024","unstructured":"Gopireddy RR, Maruthapillai A, Mahapatra S. A multi-analyte LC-MS\/MS method for determination and quantification of six nitrosamine impurities in sartans like azilsartan, valsartan, telmisartan, olmesartan, losartan and irbesartan. J Chromatogr Sci 2024; 62: 147\u2013167.","journal-title":"J Chromatogr Sci"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1039\/D2AY01821G","article-title":"A highly sensitive LC-MS\/MS method for the determination and quantification of a recently identified N-nitrosamine impurity in the sitagliptin phosphate monohydrate active pharmaceutical ingredient","volume":"15","author":"Wang Z","year":"2023","unstructured":"Wang Z, Hu S, Wu X, et al. A highly sensitive LC-MS\/MS method for the determination and quantification of a recently identified N-nitrosamine impurity in the sitagliptin phosphate monohydrate active pharmaceutical ingredient. Anal Methods 2023; 15: 256\u2013260. https:\/\/doi.org\/10.1039\/D2AY01821G.","journal-title":"Anal Methods"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"123593","DOI":"10.1016\/j.jchromb.2023.123593","article-title":"Development of a sensitive LC-APCI-MS\/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach","volume":"1216","author":"Mavis ME","year":"2023","unstructured":"Mavis ME, Goksu Gursu G, Ular Cagatay N. Development of a sensitive LC-APCI-MS\/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach. J Chromatogr B Analyt Technol Biomed Life Sci 2023; 1216: 123593. 20230113.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.xphs.2023.01.005","article-title":"Investigation of carcinogenic impurities of N-nitrosamines in sartan pharmaceutical products marketed in Brazil: development and validation of method based on high-performance liquid chromatography-tandem mass spectrometry","volume":"112","author":"Monteiro MA","year":"2023","unstructured":"Monteiro MA, de Lima PC, Novotny TS, et al. Investigation of carcinogenic impurities of N-nitrosamines in sartan pharmaceutical products marketed in Brazil: development and validation of method based on high-performance liquid chromatography-tandem mass spectrometry. J Pharm Sci 2023; 112: 1305\u20131314.","journal-title":"J Pharm Sci"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.202300125","article-title":"Ultra high speed liquid chromatography combined with mass spectrometry detection analytical methods for the determination of nitrosamine drug substance related impurities","volume":"46","author":"Marl\u00e9s-Torres A","year":"2023","unstructured":"Marl\u00e9s-Torres A, L\u00f3pez-Garc\u00eda R, Bessa-Jambrina S, et al. Ultra high speed liquid chromatography combined with mass spectrometry detection analytical methods for the determination of nitrosamine drug substance related impurities. J Sep Sci 2023; 46: e2300125.","journal-title":"J Sep Sci"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"115685","DOI":"10.1016\/j.jpba.2023.115685","article-title":"A comprehensive LC-UHPLC-MS\/MS method for the monitoring of N-nitrosamines in lipophilic drugs: a case study with rifampicin","volume":"236","author":"de Souza GFP","year":"2023","unstructured":"de Souza GFP, Matos MFAV, de Castro Aglio T, et al. A comprehensive LC-UHPLC-MS\/MS method for the monitoring of N-nitrosamines in lipophilic drugs: a case study with rifampicin. J Pharm Biomed Anal 2023; 236: 115685.","journal-title":"J Pharm Biomed Anal"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.3390\/molecules28217405","article-title":"Development and validation of LC-MS\/MS method for the determination of 1-methyl-4-nitrosopiperazine (MNP) in multicomponent products with rifampicin\u2014analytical challenges and degradation studies","volume":"28","author":"Witkowska AB","year":"2023","unstructured":"Witkowska AB, Wo\u0142czy\u0144ska A, Lis-Cieplak A, et al. Development and validation of LC-MS\/MS method for the determination of 1-methyl-4-nitrosopiperazine (MNP) in multicomponent products with rifampicin\u2014analytical challenges and degradation studies. Molecules 2023; 28: 7405.","journal-title":"Molecules"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9747","article-title":"Development and validation of high-performance liquid chromatography-orbitrap mass spectrometric method for quantification of NDMA in ranitidine drug products and evaluation of antioxidants as inhibitors of classical nitrosation reaction","volume":"38","author":"Aishwarya D","year":"2024","unstructured":"Aishwarya D, Nikhil P, Natesan S, et al. Development and validation of high-performance liquid chromatography-orbitrap mass spectrometric method for quantification of NDMA in ranitidine drug products and evaluation of antioxidants as inhibitors of classical nitrosation reaction. Rapid Commun Mass Spectrom 2024; 38: e9747.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"465176","DOI":"10.1016\/j.chroma.2024.465176","article-title":"A multianalyte LC-MS\/MS method for accurate quantification of nitrosamines in olmesartan tablets","volume":"1732","author":"Pawar N","year":"2024","unstructured":"Pawar N, Bhardwaj A, Vora A, et al. A multianalyte LC-MS\/MS method for accurate quantification of nitrosamines in olmesartan tablets. J Chromatogr A 2024; 1732: 465176.","journal-title":"J Chromatogr A"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1039\/D4AY00967C","article-title":"Exploration and detection of nitrosamine impurity nitroso-STG-19 in sitagliptin tablets and API as well as nitrites in excipients by LC-MS\/MS methods","volume":"16","author":"Hao YJ","year":"2024","unstructured":"Hao YJ, Fu J, Wei RX, et al. Exploration and detection of nitrosamine impurity nitroso-STG-19 in sitagliptin tablets and API as well as nitrites in excipients by LC-MS\/MS methods. Anal Methods 2024; 16: 5288\u20135295.","journal-title":"Anal Methods"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.pharma.2024.03.006","article-title":"Trace level quantification of N-nitrosorasagiline in rasagiline tablets by LC-TQ-MS\/MS","volume":"82","author":"Patel R","year":"2024","unstructured":"Patel R, Patel M, Solanki R, et al. Trace level quantification of N-nitrosorasagiline in rasagiline tablets by LC-TQ-MS\/MS. Ann Pharm Fr 2024; 82: 771\u2013779.","journal-title":"Ann Pharm Fr"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03067319.2024.2407916","article-title":"A novel fast analytical method for the determination of N-nitroso vonoprazan in vonoprazan tablets and raw materials using LC-ESI-MS\/MS","author":"Abuothman M","year":"2024","unstructured":"Abuothman M, Deeb AA, Hailat M, et al. A novel fast analytical method for the determination of N-nitroso vonoprazan in vonoprazan tablets and raw materials using LC-ESI-MS\/MS. Int J Environ Anal Chem 2024: 1\u201310. DOI: https:\/\/doi.org\/10.1080\/03067319.2024.2407916","journal-title":"Int J Environ Anal Chem"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1039\/D4AY01067A","article-title":"Development of a sensitive LC-MS\/MS method for determination of N-nitrosopiperazine in levocetirizine","volume":"16","author":"Lim Y","year":"2024","unstructured":"Lim Y, Kim A, Lee YM, et al. Development of a sensitive LC-MS\/MS method for determination of N-nitrosopiperazine in levocetirizine. Anal Methods 2024; 16: 6494\u20136500.","journal-title":"Anal Methods"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"112439","DOI":"10.1016\/j.microc.2024.112439","article-title":"Development of a sensitive LC-MS\/MS method for simultaneous determination of three nitrosamines in losartan API and assessment of nitrosamines formation","volume":"208","author":"Carlos G","year":"2025","unstructured":"Carlos G, Martini PRR, Machioli LF, et al. Development of a sensitive LC-MS\/MS method for simultaneous determination of three nitrosamines in losartan API and assessment of nitrosamines formation. Microchem J 2025; 208: 112439.","journal-title":"Microchem J"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pharma.2023.08.002","article-title":"LC-MS\/MS investigation of nitrosamine impurities in certain sartan group medicinal products available in Istanbul, t\u00fcrkiye","volume":"82","author":"\u00d6nc\u00fc T","year":"2024","unstructured":"\u00d6nc\u00fc T, Y\u00fcksel B, Binay E, et al. LC-MS\/MS investigation of nitrosamine impurities in certain sartan group medicinal products available in Istanbul, t\u00fcrkiye. Ann Pharm Fr 2024; 82: 72\u201383.","journal-title":"Ann Pharm Fr"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"113460","DOI":"10.1016\/j.jpba.2020.113460","article-title":"Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans, metformin and ranitidine by precipitation and solid phase extraction and gas chromatography-tandem mass spectrometry","volume":"189","author":"Lim HH","year":"2020","unstructured":"Lim HH, Oh YS, Shin HS. Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans, metformin and ranitidine by precipitation and solid phase extraction and gas chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2020; 189: 113460. 20200704.","journal-title":"J Pharm Biomed Anal"},{"key":"e_1_3_2_41_2","first-page":"1","article-title":"Development of a sensitive and stable GC-MS\/MS method for simultaneous determination of four N-nitrosamine genotoxic impurities in sartan substances","volume":"12","author":"Liu J","year":"2021","unstructured":"Liu J, Xie B, Mai B, et al. Development of a sensitive and stable GC-MS\/MS method for simultaneous determination of four N-nitrosamine genotoxic impurities in sartan substances. J Anal Sci Technol 2021; 12: 1\u20138.","journal-title":"J Anal Sci Technol"},{"key":"e_1_3_2_42_2","first-page":"31","article-title":"Screening of nitrosamine impurities in sartan pharmaceuticals by GC-MS\/MS","volume":"12","author":"Chang S-H","year":"2021","unstructured":"Chang S-H, Ho H-Y, Zang C-Z, et al. Screening of nitrosamine impurities in sartan pharmaceuticals by GC-MS\/MS. Mass Spectrom Lett 2021; 12: 31\u201340.","journal-title":"Mass Spectrom Lett"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"121659","DOI":"10.1016\/j.talanta.2020.121659","article-title":"Development of a new methodology for the determination of N-nitrosamines impurities in ranitidine pharmaceuticals using microextraction and gas chromatography-mass spectrometry","volume":"223","author":"Gim\u00e9nez-Campillo C","year":"2021","unstructured":"Gim\u00e9nez-Campillo C, Pastor-Belda M, Campillo N, et al. Development of a new methodology for the determination of N-nitrosamines impurities in ranitidine pharmaceuticals using microextraction and gas chromatography-mass spectrometry. Talanta 2021; 223: 121659. 20200915.","journal-title":"Talanta"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1039\/D1AY01036K","article-title":"A solvent-free headspace GC\/MS method for sensitive screening of N-nitrosodimethylamine in drug products","volume":"13","author":"Hwang SH","year":"2021","unstructured":"Hwang SH, Park S, Lee J, et al. A solvent-free headspace GC\/MS method for sensitive screening of N-nitrosodimethylamine in drug products. Anal Methods 2021; 13: 3402\u20133409.","journal-title":"Anal Methods"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1021\/acsomega.1c00982","article-title":"Development of a sensitive headspace gas chromatography-mass spectrometry method for the simultaneous determination of nitrosamines in losartan active pharmaceutical ingredients","volume":"6","author":"Wichitnithad W","year":"2021","unstructured":"Wichitnithad W, Sudtanon O, Srisunak P, et al. Development of a sensitive headspace gas chromatography-mass spectrometry method for the simultaneous determination of nitrosamines in losartan active pharmaceutical ingredients. ACS Omega 2021; 6: 11048\u201311058. 20210416.","journal-title":"ACS Omega"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"20221012","DOI":"10.3390\/ijms232012125","article-title":"Development of a sensitive screening method for simultaneous determination of nine genotoxic nitrosamines in active pharmaceutical ingredients by GC-MS","volume":"23","author":"Witkowska AB","year":"2022","unstructured":"Witkowska AB, Giebu\u0142towicz J, D\u0105browska M, et al. Development of a sensitive screening method for simultaneous determination of nine genotoxic nitrosamines in active pharmaceutical ingredients by GC-MS. Int J Mol Sci 2022; 23 : 20221012.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.xphs.2023.03.016","article-title":"Dispersant-First dispersive liquid-liquid microextraction (DF-DLLME), a novel sample preparation procedure for NDMA determination in metformin products","volume":"112","author":"G\u00e9hin C","year":"2023","unstructured":"G\u00e9hin C, O'Neill N, Moore A, et al. Dispersant-First dispersive liquid-liquid microextraction (DF-DLLME), a novel sample preparation procedure for NDMA determination in metformin products. J Pharm Sci 2023; 112: 2453\u20132462.","journal-title":"J Pharm Sci"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"464323","DOI":"10.1016\/j.chroma.2023.464323","article-title":"Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry","volume":"1708","author":"Kalauz A","year":"2023","unstructured":"Kalauz A, Tiringer KV, Horv\u00e1th V, et al. Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry. J Chromatogr A 2023; 1708: 464323.","journal-title":"J Chromatogr A"},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.3390\/app11167590","article-title":"Development and validation of a method for the semi-quantitative determination of n-nitrosamines in active pharmaceutical ingredient enalapril maleate by means of derivatisation and detection by HPLC with fluorimetric detector","volume":"11","author":"Boczar D","year":"2021","unstructured":"Boczar D, Wyszomirska E, Zabrzewska B, et al. Development and validation of a method for the semi-quantitative determination of n-nitrosamines in active pharmaceutical ingredient enalapril maleate by means of derivatisation and detection by HPLC with fluorimetric detector. Appl Sci 2021; 11: 7590.","journal-title":"Appl Sci"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/separations9110347","article-title":"Development and validation of an HPLC-FLD method for the determination of NDMA and NDEA nitrosamines in lisinopril using pre-column denitrosation and derivatization procedure","volume":"9","author":"Tsanaktsidou E","year":"2022","unstructured":"Tsanaktsidou E, Kanata L, Almpani S, et al. Development and validation of an HPLC-FLD method for the determination of NDMA and NDEA nitrosamines in lisinopril using pre-column denitrosation and derivatization procedure. Separations 2022; 9: 347.","journal-title":"Separations"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"220250","DOI":"10.1098\/rsos.220250","article-title":"Cost-effective, green HPLC determination of losartan, valsartan and their nitrosodiethylamine impurity: application to pharmaceutical dosage forms","volume":"9","author":"Abd El-Hay SS","year":"2022","unstructured":"Abd El-Hay SS, Elhenawee M, Maged K, et al. Cost-effective, green HPLC determination of losartan, valsartan and their nitrosodiethylamine impurity: application to pharmaceutical dosage forms. R Soc Open Sci 2022; 9: 220250. 20220601.","journal-title":"R Soc Open Sci"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.xphs.2022.11.029","article-title":"Thymol-based hydrophobic deep eutectic solvents as a green approach for screening polar nitrosamines in sartans pharmaceutical products by ultrasound-assisted dispersive liquid-liquid microextraction combined with HPLC-DAD","volume":"112","author":"Novotny TS","year":"2023","unstructured":"Novotny TS, Monteiro MA, de Lima PC, et al. Thymol-based hydrophobic deep eutectic solvents as a green approach for screening polar nitrosamines in sartans pharmaceutical products by ultrasound-assisted dispersive liquid-liquid microextraction combined with HPLC-DAD. J Pharm Sci 2023; 112: 1231\u20131245.","journal-title":"J Pharm Sci"}],"container-title":["European Journal of Mass Spectrometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14690667251328823","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/14690667251328823","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14690667251328823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:04:41Z","timestamp":1777406681000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/14690667251328823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":51,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1177\/14690667251328823"],"URL":"https:\/\/doi.org\/10.1177\/14690667251328823","relation":{},"ISSN":["1469-0667","1751-6838"],"issn-type":[{"value":"1469-0667","type":"print"},{"value":"1751-6838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}